Table 2.
Adjusteda
|
|||||
---|---|---|---|---|---|
Demographic Characteristic | Visits with benzodiazepines (n=1,748) | Visits without benzodiazepines (n=30,796) | p | ORb | 95% CI |
Age | |||||
65–74 years, %c (ref) | 45.3 | 50.0 | n/a | 1.00 | n/a |
75–84 years | 38.5 | 37.0 | .05 | 1.16 | 1.01–1.33 |
85+ years | 16.2 | 13.0 | .006 | 1.40 | 1.12–1.77 |
Sex | |||||
Male (ref) | 31.7 | 43.7 | n/a | 1.00 | n/a |
Female | 68.3 | 56.3 | <0.001 | 1.61 | 1.38–1.88 |
Ethnicity | |||||
Non-Hispanic white (ref) | 82.5 | 79.8 | n/a | 1.0 | n/a |
Non-Hispanic black | 7.1 | 8.1 | .29 | .87 | .67–1.13 |
Hispanic | 8.3 | 8.9 | .96 | .99 | .76–1.30 |
Other | 2.1 | 4.0 | .005 | .52 | .33–.82 |
Adjusteda
|
|||||
---|---|---|---|---|---|
Demographic Characteristic | Continuation benzodiazepines (n=1,559) | New benzodiazepines (n=189) | p | ORd | 95% CI |
Age | |||||
65–74 years, % (ref) | 44.8 | 49.0 | n/a | 1.00 | n/a |
75–84 years | 38.0 | 41.6 | .99 | .95 | .62–1.45 |
85+ years | 17.2 | 9.3 | .09 | 1.96 | .82–4.67 |
Sex | |||||
Male (ref) | 31.2 | 35.2 | n/a | 1.00 | n/a |
Female | 68.8 | 64.8 | .55 | 1.21 | .66–2.22 |
Ethnicity | |||||
Non-Hispanic white | 83.6 | 75.3 | n/a | 1.00 | n/a |
Non-Hispanic black | 6.2 | 13.6 | .009 | .38 | .18–.78 |
Hispanic | 8.4 | 7.4 | .96 | 1.14 | .45–2.90 |
Other | 1.9 | 3.7 | .11 | .39 | .15–1.06 |
Adjusted for diagnosis or reason for visit of anxiety and insomnia.
OR: odds ratio reflecting the odds associated with benzodiazepine use.
Percentage of visit with a given characteristic, unless noted otherwise.
Reflects the odds associated with continuation benzodiazepine use.